Study record

Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging

Wan W, Zhang L, Lin Y et al. · J Transl Med · 2023

ReviewSeveralEvidence tier R

What this study reported

Reviewed published work describing MOTS-c as a peptide encoded by the mitochondrial 12S rRNA gene that is reported to translocate to the nucleus under stress and to act largely through a folate-AICAR-AMPK route. Summarised reported links to energy metabolism, insulin resistance, inflammatory responses, exercise and aging-related processes across cell, animal and human studies.

Limitations

Narrative review with no stated search strategy, inclusion criteria or risk-of-bias assessment; the summarised evidence is mostly preclinical and is not weighted by study quality.

Study record

Annotated fields for this study
Study modelReview
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
SpeciesNot reported
System studiedPublished literature on MOTS-c in stress responses, energy metabolism and aging
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredretrograde mitochondrial-to-nuclear signalling; energy metabolism and insulin resistance; stress homeostasis; aging-related pathology
Pathways measuredFolate cycle / purines / AICAR · AMPK signalling · Nuclear translocation · NRF2 / antioxidant response
Research areasAging · Metabolic · Mitochondrial biology
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article, Review, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.